查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790122

美国医疗旅游市场规模、份额和趋势分析报告：按类型、消费行为、主要企业、竞争分析和细分预测，2025-2023 年

U.S. Medical Tourism Market Size, Share & Trends Analysis Report By Type (Inbound Medical Tourism, Outbound Medical Tourism), Consumer Behavior, Key Companies, Competitive Analysis, And Segment Forecasts, 2025 - 203
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国医疗旅游市场规模及趋势：

美国医疗旅游市场规模预计在 2024 年达到 87.4 亿美元，预计到 2033 年将达到 265.8 亿美元，预测期内复合年增长率为 13.20%。

近年来，受国际认证医院数量的不断增长及其提供尖端治疗的声誉的推动，医疗市场经历了显着增长。美国医疗机构越来越重视以患者为中心的个人化护理，这是该国医疗旅游业发展的主要驱动力。

医院和诊所越来越注重根据患者的个别需求量身定制治疗方案，提供个人化护理计划，并提升患者的整体体验。这种高品质、以患者为中心的医疗服务预计将受到寻求更个人化医疗方案的国际患者的热烈追捧。

美国拥有众多获得国际认证的医院，这推动了入境医疗旅游的成长。随着全球患者在医疗保健决策中越来越重视安全性、品质和透明度，美国正透过提供符合严格国际标准的医疗机构，将自己定位为首选目的地。根据美国国际患者计画合作协会 (USCIPP) 2023 年的报告，60 家美国机构在一个财政年度内为 47,002 名国际患者累计了服务，总合收入达 21 亿美元。此外，获得国际联合委员会 (JCI)、全球医疗保健认证 (GHA) 和挪威船级社 (DNV-GL) 等全球公认机构认证的医院在竞争激烈的医疗旅游市场中脱颖而出，让患者对医疗品质和诊疗流程的完整性感到安心。

此外，拥有国际培训经验的医生对支持美国入境医疗旅游的发展发挥关键作用。这些医生通常被称为国际医学毕业生 (IMG)，构成了美国医疗保健团队的重要组成部分。根据《住院医师杂誌》(The Hospitalist) 报道，到 2023 年，美国约有 25% 的在职医师将是 IMG。这些医生来自印度、巴基斯坦和奈及利亚等多个国家，拥有丰富的临床专业知识和多语言能力。这些素质增强了临床团队的实力，并创造了文化敏感的医疗环境，这对于寻求个人化、贴心医疗体验的国际患者尤其重要。

此外，美国医疗旅游的主要驱动力之一是该国极高的医疗成本。根据美国医疗保险和医疗补助服务中心 (CMS) 的数据，到 2022 年，美国全国医疗支出将达到 4.5 兆美元，人均约 13,493 美元，约占 GDP 的 17.3%。这些数字显示美国医疗保健的巨大经济负担。

同时，根据美国人口普查局的数据，到2023年，大约8%的美国人口仍然没有保险，92%的人口将拥有保险。即使是那些有保险的人，也经常会遇到高额的免赔额、共同支付或共同保险，这使得许多重要的治疗在经济上难以承受。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国医疗旅游：市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 商业环境分析工具
    • 波特五力分析
    • PESTLE分析

第四章：美国入境医疗旅游市场分析

  • 2018-2030年美国入境医疗旅游市场规模预测
    • 监管和报销情况
    • 2024入境治疗/程序分析（程序类型）
    • 2024 年住院病患分析 (%) (病患来源)
    • 2018年至2030年住院病患分析（人数）
    • 2024年每位患者的平均支出

第五章 竞争分析

  • 公司分类
  • 企业市场分析
  • 战略地图
  • 公司简介/上市公司
    • Cleveland Clinic
    • Mayo Clinic
    • The Johns Hopkins Hospital
    • Cedars-Sinai
    • Massachusetts General Hospital
    • UCSF Health
    • NewYork-Presbyterian Hospital
    • Ronald Reagan UCLA Medical Center
    • Northwestern Memorial Hospital
    • Stanford Health Care

第六章美国出境医疗旅游：市场变数、趋势与范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 商业环境分析工具
    • 波特五力分析
    • PESTLE分析

第七章美国出境医疗旅游市场分析

  • 2018-2030年美国出境医疗旅游市场规模预测
  • 2018-2030年各国情况
    • 墨西哥
    • 加拿大
    • 印度
    • 哥斯大黎加
    • 泰国
    • 巴西
    • 其他国家
    • 门诊治疗及手术分析（手术类型）2024
    • 2018年至2030年门诊病人分析（患者人数）

第八章美国出境医疗旅游市场：保险覆盖范围

  • 出境医疗旅游医疗保险覆盖率：定性分析

第九章美国出境医疗旅游市场：策略框架

  • 策略倡议
  • 促进国际医疗旅游的伙伴关係和合作
  • 吸引美国病患的美国境外主要国际医院
Product Code: GVR-4-68038-096-5

U.S. Medical Tourism Market Size & Trends:

The U.S. medical tourism market size was estimated at USD 8.74 billion in 2024 and is projected to grow at a CAGR of 13.20% over the forecast period to reach an estimated value of USD 26.58 billion by 2033. The market has experienced significant growth in recent times, driven by the increasing presence of internationally accredited hospitals and the reputation for providing cutting-edge medical treatments. The growing emphasis on personalized and patient-centric care in U.S. healthcare facilities is significantly driving the medical tourism industry in the country.

Hospitals and clinics increasingly focus on tailored treatments to individual patient needs, providing personalized care plans, and enhancing the overall patient experience. This high-quality, patient-centered care is expected to witness high demand from international patients seeking an advanced and customized approach to their health.

The presence of internationally accredited hospitals in the U.S. is driving the growth of the inbound medical tourism. As global patients increasingly prioritize safety, quality, and transparency in their healthcare decisions, the U.S. has positioned itself as a preferred destination by offering facilities that meet stringent international standards. As per the 2023 report by The U.S. Cooperative for International Patient Programs (USCIPP), 60 different U.S. organizations assisted 47,002 international patients and reported gross revenue charges totaling USD 2.1 billion in a single fiscal year. Furthermore, hospitals accredited by globally recognized organizations such as Joint Commission International (JCI), Global Healthcare Accreditation (GHA), and DNV-GL stand out in a competitive medical tourism landscape, offering reassurance to patients regarding care quality and procedural integrity.

Moreover, the presence of internationally trained physicians plays a significant role in supporting the growth of the U.S. inbound medical tourism industry. These physicians, commonly referred to as International Medical Graduates (IMGs), comprise a substantial portion of the national medical workforce. According to The Hospitalist, in 2023, nearly 25 percent of active physicians in the U.S. were IMGs. These physicians originate from a wide range of countries, including India, Pakistan, and Nigeria, and bring with them diverse clinical expertise and multilingual capabilities. These qualities strengthen the clinical workforce and foster a culturally sensitive care environment that is especially valuable for international patients seeking personalized and familiar care experiences.

Furthermore, one of the primary drivers of outbound medical tourism from the U.S. is the exceptionally high cost of healthcare domestically. According to the Centers for Medicare & Medicaid Services (CMS), U.S. national health expenditures reached USD 4.5 trillion in 2022, averaging approximately USD 13,493 per person, accounting for about 17.3 percent of GDP. These figures underscore the steep financial burden of healthcare in the U.S.

Meanwhile, the U.S. Census Bureau reports that roughly 8 percent of the U.S. population remained uninsured in 2023, with a similar proportion, 92 percent, insured at some point during the year. Even those who are insured often encounter high deductibles, copayments, or coinsurance, making many vital treatments financially inaccessible.

U.S. Medical Tourism Market Report Segmentation

This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. medical tourism market report based on type.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Inbound Medical Tourism
  • Outbound Medical Tourism

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
    • 1.2.1 Information procurement
      • 1.2.1.1 Purchased database
    • 1.2.2 GVR's internal database
      • 1.2.2.1 Secondary sources
      • 1.2.2.2 Primary research
  • 1.3 Information or Data Analysis
    • 1.3.1 Data Analysis Models
  • 1.4 Market Formulation & Validation
  • 1.5 Model Details
    • 1.5.1 Bottom Up Approach
      • 1.5.1.1 Market Estimation Framework
        • 1.5.1.1.1. Pillar I - Secondary Research
        • 1.5.1.1.2. Pillar II - Primary Research
        • 1.5.1.1.3. Pillar III - Internal Benchmarking and Modeling
      • 1.5.1.2 Segmented Estimation Approach
        • 1.5.1.2.1. Inbound Medical Tourism Estimation
        • 1.5.1.2.2. Outbound Medical Tourism Estimation
      • 1.5.1.3 Forecasting Methodology (2025 - 2030)
  • 1.6 List of Secondary Sources
  • 1.7 List of Abbreviations
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2
    • 1.8.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Market Segmentation
  • 2.3 Competitive Landscape

Chapter 3 U.S. Inbound Medical Tourism: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Presence of International Accreditation Hospitals
        • 3.2.1.1.1. Case Study: Impact of Hospital Accreditation on Medicare Patient Outcomes in the U.S.
      • 3.2.1.2 Presence of internationally trained physicians
        • 3.2.1.2.1. Case Study: Comparative Patient Outcomes Between U.S.-Trained and Foreign-Trained Physicians
      • 3.2.1.3 Access to Advanced Medical Technology and Treatments
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost of Procedures
      • 3.2.2.2 Follow-Up Problems
    • 3.2.3 Market Opportunity Analysis
      • 3.2.3.1 Partnerships with International Insurers and Governments
    • 3.2.4 Market Challenges Analysis
      • 3.2.4.1 Visa and Immigration Barriers
  • 3.3 Business Environment Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTLE Analysis

Chapter 4 U.S. Inbound Medical Tourism Market Analysis

  • 4.1 U.S. Inbound Medical Tourism Market Estimates & Forecasts, 2018 to 2030 (USD Million)
    • 4.1.1 Regulatory & Reimbursement Scenario
      • 4.1.1.1 Regulatory Framework
      • 4.1.1.2 Reimbursement Scenario
    • 4.1.2 Inbound Treatments/Procedures Analysis, 2024 (Type of Procedures)
    • 4.1.3 Inbound Patient Analysis, 2024 (%) (Patient Origin)
    • 4.1.4 Inbound Patient Traffic Analysis, 2018 - 2030 (Number of Patients)
    • 4.1.5 Average Spend Per Patient, 2024

Chapter 5 Competitive Analysis

  • 5.1. Company Categorization
  • 5.2. Company Market Position Analysis
  • 5.3. Strategy Mapping
  • 5.4. Company Profiles/Listing
    • 5.1.1. Cleveland Clinic
      • 5.1.1.1. Overview
      • 5.1.1.2. Financial Performance
      • 5.1.1.3. Service Benchmarking
      • 5.1.1.4. Strategic Initiatives
    • 5.1.2. Mayo Clinic
      • 5.1.2.1. Overview
      • 5.1.2.2. Financial Performance
      • 5.1.2.3. Service Benchmarking
      • 5.1.2.4. Strategic Initiatives
    • 5.1.3. The Johns Hopkins Hospital
      • 5.1.3.1. Overview
      • 5.1.3.2. Financial Performance
      • 5.1.3.3. Service Benchmarking
      • 5.1.3.4. Strategic Initiatives
    • 5.1.4. Cedars-Sinai
      • 5.1.4.1. Overview
      • 5.1.4.2. Financial Performance
      • 5.1.4.3. Service Benchmarking
      • 5.1.4.4. Strategic Initiatives
    • 5.1.5. Massachusetts General Hospital
      • 5.1.5.1. Overview
      • 5.1.5.2. Financial Performance
      • 5.1.5.3. Service Benchmarking
      • 5.1.5.4. Strategic Initiatives
    • 5.1.6. UCSF Health
      • 5.1.6.1. Overview
      • 5.1.6.2. Financial Performance
      • 5.1.6.3. Service Benchmarking
      • 5.1.6.4. Strategic Initiatives
    • 5.1.7. NewYork-Presbyterian Hospital
      • 5.1.7.1. Overview
      • 5.1.7.2. Financial Performance
      • 5.1.7.3. Service Benchmarking
      • 5.1.7.4. Strategic Initiatives
    • 5.1.8. Ronald Reagan UCLA Medical Center
      • 5.1.8.1. Overview
      • 5.1.8.2. Financial Performance
      • 5.1.8.3. Service Benchmarking
      • 5.1.8.4. Strategic Initiatives
    • 5.1.9. Northwestern Memorial Hospital
      • 5.1.9.1. Overview
      • 5.1.9.2. Financial Performance
      • 5.1.9.3. Service Benchmarking
      • 5.1.9.4. Strategic Initiatives
    • 5.1.10. Stanford Health Care
      • 5.1.10.1. Overview
      • 5.1.10.2. Financial Performance
      • 5.1.10.3. Service Benchmarking
      • 5.1.10.4. Strategic Initiatives

Chapter 6 U.S. Outbound Medical Tourism: Market Variables, Trends & Scope

  • 6.1 Market Dynamics
    • 6.1.1 Market Driver Analysis
      • 6.1.1.1 High Cost of Medical Treatments
      • 6.1.1.2 Longer Waiting Time
      • 6.1.1.3 Limited Insurance Coverage for Some Procedures
    • 6.1.2 Market Restraint Analysis
      • 6.1.2.1 Medical Risks Associated with Medical Tourism
      • 6.1.2.2 Follow-Up Problems
    • 6.1.3 Market Opportunity Analysis
      • 6.1.3.1 Improved Quality and Infrastructure in Destination Countries
    • 6.1.4 Market Challenges Analysis
      • 6.1.4.1 Limited Legal Recourse and Liability Protection
  • 6.2 Business Environment Analysis Tools
    • 6.2.1 Porter's Five Forces Analysis
    • 6.2.2 PESTLE Analysis

Chapter 7 U.S. Outbound Medical Tourism Market Analysis

  • 7.1 U.S. Outbound Medical Tourism Market Estimates & Forecasts, 2018 to 2030 (USD Million)
      • 7.1.1.1 U.S. Outbound Medical Tourism market, 2018 - 2030 (USD Million)
  • 7.2 U.S. Outbound Medical Tourism Market Estimates & Forecasts, by Country, 2018 to 2030 (USD Million)
    • 7.2.1 Mexico
      • 7.2.1.1 Mexico Market, 2018 - 2030 (USD Million)
    • 7.2.2 Canada
      • 7.2.2.1 Canada Market, 2018 - 2030 (USD Million)
    • 7.2.3 India
      • 7.2.3.1 India Market, 2018 - 2030 (USD Million)
    • 7.2.4 Costa Rica
      • 7.2.4.1 Costa Rica Market, 2018 - 2030 (USD Million)
    • 7.2.5 Thailand
      • 7.2.5.1 Thailand Market, 2018 - 2030 (USD Million)
    • 7.2.6 Brazil
      • 7.2.6.1 Brazil Market, 2018 - 2030 (USD Million)
    • 7.2.7 Rest of World
      • 7.2.7.1 Rest of World Market, 2018 - 2030 (USD Million)
    • 7.2.8 Outbound Treatments/Procedures Analysis, 2024 (Type of Procedures)
    • 7.2.9 Outbound Patient Traffic Analysis, 2018 - 2030 (Number of Patients)

Chapter 8 U.S. Outbound Medical Tourism Market: Insurance Coverage

  • 8.1 Medicare Coverage for Outbound Medical Tourism: Qualitative Analysis
    • 8.1.1 Medicare Coverage for Healthcare Services in Foreign Hospitals
    • 8.1.2 Services Covered by Medicare
    • 8.1.3 Services Not Covered by Medicare
    • 8.1.4 Medicare Supplement Insurance (Medigap)
    • 8.1.5 Medicare Health Plans Other Than Original Medicare

Chapter 9 U.S. Outbound Medical Tourism Market: Strategic Framework

  • 9.1 Strategic Initiatives
  • 9.2 Partnerships & Collaborations Encouraging Outbound Medical Tourism
  • 9.3 Leading Non-U.S. Based International Hospitals Attracting U.S. Patients

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Average cardiovascular treatment price range comparison
  • TABLE 4 U.S. inbound patient traffic analysis, 2018 - 2030
  • TABLE 5 Approximate medical procedure cost comparison between the mentioned destinations (USD)
  • TABLE 6 Global JCI-accredited hospitals
  • TABLE 7 Savings comparison on medical procedures and travel times
  • TABLE 8 Average bariatric treatment price range comparison
  • TABLE 9 Average orthopedic treatment price range comparison
  • TABLE 10 Average cosmetic treatment price range comparison
  • TABLE 11 Average orthopedic treatment price range comparison with India
  • TABLE 12 Average orthopedic treatment price range comparison with Costa Rica
  • TABLE 13 U.S. average ophthalmology treatment price range comparison with Thailand
  • TABLE 14 U.S. average cosmetic treatment price range comparison with Brazil
  • TABLE 15 U.S. outbound patient traffic analysis, 2018 - 2030
  • TABLE 16 Leading non-U.S. based international hospitals

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain-based sizing & forecasting
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market snapshot
  • FIG. 9 Market segmentation
  • FIG. 10 Competitive landscape
  • FIG. 11 U.S. inbound medical tourism market dynamics
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 U.S. inbound medical tourism market: Porter's five forces analysis
  • FIG. 15 U.S. inbound medical tourism market: PESTLE analysis
  • FIG. 16 U.S. inbound medical tourism market estimates & forecasts, 2018 to 2030 (USD Million)
  • FIG. 17 U.S. inbound treatments/procedures analysis, 2024 (Type of procedures)
  • FIG. 18 U.S. inbound patient analysis, 2024 (%) (Patient origin)
  • FIG. 19 Company/competition categorization
  • FIG. 20 Company market position analysis
  • FIG. 21 Strategy mapping
  • FIG. 22 U.S. outbound medical tourism market dynamics
  • FIG. 23 Market driver relevance analysis (Current & future impact)
  • FIG. 24 Market restraint relevance analysis (Current & future impact)
  • FIG. 25 U.S. outbound medical tourism market: Porter's five forces analysis
  • FIG. 26 U.S. outbound medical tourism market: PESTLE analysis
  • FIG. 27 U.S. outbound medical tourism market, 2018 - 2030 (USD Million)
  • FIG. 28 Mexico market, 2018 - 2030 (USD Million)
  • FIG. 29 Canada market, 2018 - 2030 (USD Million)
  • FIG. 30 India market, 2018 - 2030 (USD Million)
  • FIG. 31 Costa Rica market, 2018 - 2030 (USD Million)
  • FIG. 32 Thailand market, 2018 - 2030 (USD Million)
  • FIG. 33 Brazil market, 2018 - 2030 (USD Million)
  • FIG. 34 Rest of World market, 2018 - 2030 (USD Million)
  • FIG. 35 U.S. outbound treatments/procedures analysis, 2024 (Type of procedures)